Reply to R. Fonseca et al
J Clin Oncol
.
2017 Jul 1;35(19):2218-2219.
doi: 10.1200/JCO.2017.72.8246.
Epub 2017 May 8.
Authors
Alok A Khorana
1
,
Mette Janas
1
,
Mikala F Jarner
1
,
Agnes Y Y Lee
1
Affiliation
1
Alok A. Khorana, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; Mette Janas and Mikala F. Jarner, LEO Pharma, Ballerup, Denmark; and Agnes Y.Y. Lee, University of British Columbia, Vancouver, British Columbia, Canada.
PMID:
28481706
DOI:
10.1200/JCO.2017.72.8246
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biomarkers
Humans
Prostatic Neoplasms*
Thromboplastin
Thrombosis*
Substances
Biomarkers
Thromboplastin